Chemoinformaics analysis of Artomunoxanthentrione
Molecular Weight | 444.439 | nRot | 2 |
Heavy Atom Molecular Weight | 424.279 | nRig | 30 |
Exact Molecular Weight | 444.121 | nRing | 5 |
Solubility: LogS | -6.255 | nHRing | 2 |
Solubility: LogP | 4.945 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
No. of Oxygen atom | 7 | No. of Arom Bond | 16 |
nHA | 7 | APOL | 62.3699 |
nHD | 1 | BPOL | 27.8761 |
QED | 0.568 |
Synth | 3.509 |
Natural Product Likeliness | 2.548 |
NR-PPAR-gamma | 0.794 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.992 |
Pgp-sub | 0 |
HIA | 0.032 |
CACO-2 | -5.067 |
MDCK | 0.000017 |
BBB | 0.004 |
PPB | 0.831247 |
VDSS | 0.409 |
FU | 0.106302 |
CYP1A2-inh | 0.744 |
CYP1A2-sub | 0.664 |
CYP2c19-inh | 0.846 |
CYP2c19-sub | 0.096 |
CYP2c9-inh | 0.879 |
CYP2c9-sub | 0.365 |
CYP2d6-inh | 0.148 |
CYP2d6-sub | 0.151 |
CYP3a4-inh | 0.546 |
CYP3a4-sub | 0.103 |
CL | 1.922 |
T12 | 0.055 |
hERG | 0.009 |
Ames | 0.696 |
ROA | 0.974 |
SkinSen | 0.857 |
Carcinogencity | 0.95 |
EI | 0.018 |
Respiratory | 0.586 |
NR-Aromatase | 0.937 |
Antiviral | Yes |
Prediction | 0.718577 |